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Abstract
Purpose: This study aims to clinically evaluate the directional dependence of a 2D seven29 ion-chamber array with different
intensity-modulated radiotherapy (IMRT) plans. Methods: Twenty-five patients who had already been treated with IMRT plans
were selected for the study. Verification plans were created in an Eclipse treatment planning system (TPS) for each treatment
plan. The verification plans were executed twice for each patient. The first IMRT plan used a true gantry angle (plan-related
approach), and the second plan used a 0° gantry angle (field-related approach). Measurements were performed using a Varian
Clinac 2100 iX linear accelerator. The fluence was measured for all the delivered plans and analyzed using Verisoft software. A
comparison of the fluence was performed between IMRT with a static gantry (0° gantry angle) and real gantry angles. Results:
The results indicate that the Gamma average was 98.8% for IMRT with a 0° gantry angle and 96.616% for IMRT with a true
gantry angle. Average percent difference of normalized doses for IMRT delivered with zero degree gantry angle and IMRT with
actual gantry angles is 0.15 and 0.88 respectively. Conclusion: The ion chamber of the 2D array used in IMRT verification has
angular dependence, reducing the verification accuracy when the 2D array is used for measuring the actual beams of the
treatment plan.
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Introduction
Intensity-modulated radiotherapy (IMRT) is a special type of
three-dimensional conformal radiotherapy (3D-CRT) in
which modulated fluence is delivered to the patient from
any given position of the treatment beam to optimize the
composite dose distribution. IMRT machines can vary the
strength of beams across the tumor during each dose of
treatment. Thus, the machine administers very precise doses
to an entire tumor or specific areas within the
tumor. Intensity modulation is achieved using a multileaf
collimator (MLC), and the field shape can be altered either
step-by-step or dynamically while the dose is delivered. In
the step-and-shoot mode (static IMRT) the
intensity-modulated fields are delivered in a sequence of
small segments, i.e., subfields, with a uniform intensity. This
technique requires that the beam is only turned on when the
MLC leaves are stationary in each of the prescribed subfield
positions. There is no MLC motion while the beam is turned
on. A more technically advanced method is the dynamic
MLC technique (often called the sliding-window method).
Here, the fluence profile along the moving direction of a leaf
pair is created by sweeping the leaf pair with different
openings over the field while the beam is always on.1–7
IMRT is a complicated procedure that involves the delivery
of complex intensity patterns from various gantry angles.
Owing to the complexity of the treatment plans, IMRT
requires their dosimetric verification, as it produces a steep
gradient inside tumors. Thus, patient-specific quality
assurance (QA) is very important. The pretreatment
verification of patient plans is typical for IMRT treatment.
Verification of patient-specific IMRT plans using
two-dimensional (2D) detector arrays with Octavius
phantoms has become increasingly popular because of its
easiness and the immediate readout of the results. A planar
dose at a certain depth can be extracted from the treatment
planning system (TPS) and compared with measurements
using 2D detector arrays in the same geometry at the depth
of interest. 2D dose-distribution analysis tools based on the
percent dose difference, distance to agreement (DTA), and
gamma index have been developed and implemented
commercially. The capabilities to acquire 2D dose
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distributions and perform real-time analysis make 2D
detector arrays preferable to single ion chambers and film
measurement for IMRT pretreatment verification.8
The ion-chamber-based Octavius 2D‐array detector (PTW,
Freiburg, Germany) is a step toward measuring the absolute
dose and dose distribution for patient-specific IMRT QA.
However, the directional dependency of this detector makes
it unsuitable for angle-dependent IMRT QA. However, a
new Octavius system (PTW, Freiburg, Germany) has an air
cavity that compensates for the reduced response due to
directional dependence. In the present study, we clinically
investigated the effects of the directional dependence of the
2D ion-chamber array on different IMRT plans.
Methods and Materials
We selected 25 IMRT plans with Sliding Window method,
and the disease sites mostly included prostate, lung, head and
neck, esophagus, cervix, rectum, and stomach cancer. All of
the calculations for each plan were performed using Eclipse
TPS (version 10) and the Analytical Anisotropic Algorithm
(AAA) with dose calculation grid size of 2.5mm. The
measurements were performed using a PTW 2D seven29
ion-chamber array (PTW, Freiburg, Germany) with an
Octavius phantom on a Varian Clinac iX (Varian medical
systems, Palo Alto, CA) linear accelerator. Figure 1 shows
the experimental setup of the pretreatment QA tests for
IMRT.
PTW 2D ion-chamber array
The 2DARRAY seven29 (PTW, Freiburg, Germany) is a new
concept of an ion-chamber matrix in a plane for IMRT
verification and quality control (QC) in radiation therapy.
Utilizing ion chambers avoids radiation damages, which are
the major drawback of solid state detectors. The matrix
comprises 729 vented plane parallel ion chambers, each 5
mm × 5 mm × 5 mm in size, with a center-to-center spacing
of 10 mm. It is a 27 × 27matrix, yielding a maximum field
size of 27 cm × 27 cm. The array is only 22 mm long and 3.2
kg in weight. The surrounding material is polyemethyl
methacrylate (PMMA). Owing to the square-chamber
technology, the array can be moved by 5 mm to close the
gaps between the chambers. By shifting the array three
times, the whole area is covered. The number of measured
points can be increased to 2916. The 2D array seven29 can be
used in either a flat phantom or the octagonal Octavius
phantom. With Octavius, the 2D array seven29 is suitable for
IMAT and Tomotherapy. The measurement ranges for PTW
seven29 specified by the manufacturer are 200 mGy – 1000
Gy and 500 mGymin-1 –8Gymin-1. The 2D array is calibrated
for absolute dosimetry in a Co60 photon beam at the PTW
secondary standard dosimetry laboratory. The
2Darrayseven29 can be used for IMRT plan verification,
LINAC QC, and online LINAC adjustment.3
The data-acquisition software Matrix Scan is used to acquire
dose and dose rate data. It displays 3D graphics and transfers
the acquired data to the software package Verisoft. We used
Verisoft to compare the dose distribution calculated in the
TPS with that measured by the 2Darray. The maximum and
average deviation between the treatment plan and measured
beam were determined.
FIG. 1: Experimental Set-up for the pre treatment quality assurance
tests for IMRT. PTW 2D ionization chamber array inserted inside
the Octavius CT phantom, SSD was kept at 84 cm.
Octavius phantom
A dedicated Octavius phantom was used during
measurements for the QA of the rotational treatments
(Volumetric Modulated Arc Therapy (VMAT) and
Tomotherapy), The Octavius phantom is dedicated for
rotational and intensity modulated technique quality
assurance, focusing primarily on the use of the seven29 2D
ion-chamber array. It was made of polystyrene (physical
density 1.04 g/cm3), 32 cm wide, and 32 cm long. A 30 × 30
×2.2 cm3 central cavity allowed the user to insert the 2D
ion-chamber array into the phantom. The position of the
cavity was such that when the 2D array was inserted, the
plane through the middle of the ion chambers passed
through the center of the phantom.3
FIG. 2: Octavius phantom set (LINAC phantom and CT phantom).
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The Octavius set was composed of two phantoms: a
Computed Tomography (CT) phantom and a LINAC
phantom as shown in Figure 2. The LINAC phantom had a 2
cm semicircular air cavity in its lower part to compensate for
the reduced response behavior of the seven29 2D array when
irradiated from the back. The LINAC phantom is used for
measurements, whereas the CT phantom comes without a
cavity and is used for dose planning3.
Clinical verification of IMRT QA
The Octavius CT phantom was CT scanned with the 2D
array. The scanned images were imported into the Eclipse 10
TPS. A verification plan was created for all the patients using
the 2D array and Octavius phantom. The calculations were
performed using the AAA algorithm. The dose distribution
in the phantom was recalculated without changing any
dosimetrically relevant treatment parameters. The newly
calculated patient plan or verification plan was implemented
using the LINAC phantom. In this study verification plans
were produced twice for each patient. The first plan
employed IMRT with a true gantry angle (plan-related
approach), and the second plan employed IMRT with a
0°gantry angle (field-related approach). Figure 3 shows
verification-plan window in Eclipse TPS a) for IMRT and b)
for IMRT with a 0° gantry angle. We first created the
verification plan for IMRT with true gantry angles; i.e., all
the fields with their correct beam-entry directions were
transferred within the TPS to a verification phantom, and
the dose distribution was calculated. For the field-related
approach (IMRT delivered with 0° gantry angle), each
treatment field was transferred to a verification phantom
with the gantry angle normally set to 0° for all beams
without changing other treatment parameters. The Octavius
LINAC phantom delivered each verification plan separately
for the different patients. Measurements were performed on
a Varian Clinac 2100 iX linear accelerator equipped with a
Millennium 120 MLC. The measurement values were
recorded in the 2D array seven29 ion chamber and Verisoft
using an array interface and an RS 232 cable. The fluence
was measured for all the delivered plans and analyzed using
Verisoft. All of the individual field delivered-dose
distribution patterns were added to obtain the composite
dose distribution, which was compared with the
TPS-generated composite dose distribution using the
gamma-index method proposed by Low et al.9 The spatial
difference in the dose distribution (distance-to-agreement)
and dose deviation (delta-dose) were within the clinical
acceptance criteria of 3mm and 3%, respectively. If the
gamma index was less than or equal to 1, the criteria limits
were not exceeded. When it was greater than 1, the
measurement result was outside the tolerance range. A
comparison was performed between the fluence for IMRT
with a static gantry (0° gantry angles) and that for IMRT
with real gantry angles.
FIG. 3 a): Verification plan window in eclipse treatment planning system for IMRT.
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FIG. 3 b): Verification plan window in eclipse treatment planning system for IMRT with zero degree gantry angle.
FIG. 4: Gamma pass percentage for IMRT delivered with 0 degree gantry angle and IMRT with actual gantry angle for different plan.
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FIG. 5 a): Gamma analysis for IMRT delivered with zero degree gantry angle.
FIG. 5 b): Gamma analysis for IMRT delivered with true gantry angle.
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Results
A gamma evaluation was conducted for the IMRT with
actual gantry angles and IMRT with 0° gantry angles. Figure
4 shows the variation between these two conditions for
different plans. The Gamma average was 98.8 % for IMRT
with a 0° gantry angle and 96.616% for IMRT with a true
gantry angle. Figure 5 a) and b) showing gamma analysis of
measured against TPS calculated for IMRT delivered with
zero degree gantry angles and IMRT with actual gantry
angles. The average percent difference of normalized doses
for IMRT delivered with zero degree gantry angle and IMRT
with actual gantry angles were 0.15 and 0.88, respectively.
The gamma analysis revealed a significant difference with
significance of p = 0.002 between IMRT with a 0° gantry
angle and IMRT with actual gantry angles. The standard
deviations of the gamma pass percentage for IMRT with a
0°gantry angle and with actual gantry angles were 0.678 and
0.742, respectively.
Discussions
Several researchers have investigate the angular dependence
of 2D arrays in IMRT and volumetric modulated arc therapy
(VMAT).1–13 In the study ‘characterization of the response of
the seven29 2D array detector’ 11 by Syam et al., the
detector’s directional dependence was measured as a
function of the beam angles and verified by delivering an
open field. In the present study, we clinically investigated
the angular dependence of a 2D ion-chamber array for IMRT
dose verification and quantified the influence of the
directional dependence on the effectiveness of the treatment
with different IMRT plans. The percentage variations
between the calculated and measured TPS values were found
to be 2% for IMRT with a 0° gantry angle (field-related
approach) and 5% for IMRT delivered with actual beam
gantry angles. For IMRT and IMRT with zero degree gantry
angle, the percentage variation of central detector value was
found using the formula = (measured - planned)/planned) ×
100. Figure 4 shows the gamma pass percentage for IMRT
with a static field (0° gantry angle) and IMRT delivered with
actual gantry angles. This graph indicates that the gamma
values for static IMRT (0° gantry angle) and IMRT with
actual gantry angles were average was 98.8 % and 96.61%,
respectively.
Shimohigashi et al. 4, Qilinli et al. 6, and Hussein et al. 7
calculated the percentage variation between gamma values
calculated by a TPS and those measured by a 2D array,
reporting a large variation at beam incidence angles within
90° ± 5°. These studies confirmed that 2D arrays exhibit a
reduced response if irradiated from the back. In the present
study, the 2D array exhibited directional dependence when
IMRT QA was performed with true gantry angles but not for
IMRT with a 0° gantry angle. The percentage variation of
gamma values between IMRT delivered with a 0° gantry
angle and IMRT with actual gantry angles is 3%; thus, the
directional dependence does not have a significant clinical
impact on IMRT plans.
Because the 2D array exhibits angular dependence, the
verification accuracy of IMRT with actual treatment plans is
relatively small when measured using a 2D array.
Consequently, all the beam gantry angles were modified to
0° for the verification of IMRT treatment plans.
Furthermore, IMRT with a 0° gantry angle is quick
compared with IMRT with actual gantry angles. However,
the MLC assembled in the LINAC probably has some
positioning errors when the gantry angle is not 0°,which
cause a slight discrepancy between the actual dose
distribution of the treatment plan and that computed by a
TPS.15, 16This discrepancy cannot be detected by verification
at a 0° gantry angle. In addition, the method of verification
at a 0° gantry angle cannot determine where the error has
happened, nor does it indicate the impact on the actual
implementation of the treatment plan. Thus, the best
verification method for IMRT treatment plans is to measure
the composite dose distribution under real irradiation
conditions, except if QA is performed with dosimetric
equipment having directional dependence.
Conclusion
In a gamma analysis, IMRT with a 0° gantry angle exhibited
a higher pass percentage than IMRT with true gantry angles.
The 2D-seven29 ion-chamber array used for IMRT
verification has angular dependence, which lowers the
verification accuracy when the array is used to measure
actual beam angles.
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